SlideShare uma empresa Scribd logo
1 de 72
Baixar para ler offline
G. Ross Baker, Peter G. Norton, Virginia Flintoft,
    Régis Blais, Adalsteinn Brown, Jafna Cox, Ed
  Etchells, William A. Ghali, Philip Hébert, Sumit R.
 Majumdar, Maeve O'Beirne, Luz Palacios-Derflingher,
      Robert Reid, Sam Sheps, Robyn Tamblyn

 The Canadian Adverse Events
Study: The Incidence Of Adverse
Events Among Hospital Patients
           In Canada

          Research funded by CIHI and CIHR
            philip.hebert@sunnybrook.ca
                    May 11, 2006
Outline
•   Our national study
•   Other studies, briefly
•   Our methods
•   Results
•   Limitations
•   Implications


                      © May 11, 2006   2
First and only national study of
incidence of adverse events in
      Canadian healthcare
© May 11, 2006   4
British
                 Columbia




© May 11, 2006              5
Alberta




© May 11, 2006   6
Ontario




 © May 11, 2006   7
Québec




  © May 11, 2006   8
Nova Scotia




    © May 11, 2006   9
Study Reviewers
Nova Scotia: Brenda Brownell, Dr. Tom Casey, Dr. John Fraser, Kelly
Goudey, Dr. Ron Gregor, Celeste Latter, and Dr. Allan Shlossberg
Québec : Dr. Edouard Bastien; Dr. Richard Clermont, Evelyne Jean,
Cécile Lavoie, Dr. André Rioux. Julie Robindaine, and Daphney St-
Germain
Ontario: Dr. Ed Etchells, Virginia Flintoft, Wilhelmine Jones, Dr. Peter
Kopplin, Dr. David MacPherson, and Elaine Thiel
Alberta: Fatima Chatur, Dr. Leslie Cunning, Dr. Peter Hamilton, Dr.
Narmin Kassam and Carolyn Nilsson
British Columbia: Karen Cardiff, Dr. Robert Crossland, Dr. Iain
Mackie, Cheryl Marr, Dr. Jacob Meyerhoff, Eva Somogyi and Dr.
Robert Wakefield



                              © May 11, 2006                         10
Study Goals
1. To identify the incidence of adverse events in a
   representative sample of Canadian hospitals
2. To compare the incidence between medical and
   surgical patients and between different types of
   hospitals
3. To compare the incidence to similar studies in
   England, Australia, New Zealand and elsewhere




                      © May 11, 2006            11
Example
• 77 year-old male with a long history of renal
  stones was seen in ER with hematuria
• CT revealed renal stones AND a large renal
  mass with nodules in lungs
• CT done 1 year previously revealed a
  smaller renal mass and no nodules
• His urologist had seen that CT report but
  missed the conclusion as did several others
                    © May 11, 2006          12
Example
• An adverse event and (likely) preventable
  (ie., potentially curable last year, now not)
• Caused by an omission….
  – If only, the radiologist had called
  – If only, the resident had seen the XRay
  – If only, the staffman had read the report
  – If only, other urologists had read the report
  – If only the patient had complained…


                      © May 11, 2006                13
Not at all unique
Harvard Medical Practice Study
NEJM Feb 1991

• Review of 30,121 randomly selected medical
  records from 51 NY acute care hospitals for
  patients in 1984
• Purpose: incidence of medical negligence
• Adverse events occurred in 4% of hospitalizations;
  28% of these were due to negligence (=1%
  hospitalizations)
• 71% of AE’s gave rise to disabilities < 6 months
• 14% resulted in patient’s death: 1/200
  admissions!

                      © May 11, 2006            15
Quality In Australian Health Care
  Study Med J Australia Nov 1995
• 14,000 admissions to 28 hospitals in New South Wales
  and South Australia
• Used HMPS methods, but redefined AE
• 17% of admissions had an adverse event
• 50% preventable.
• 77% lasted < 12 months;
• 5% of the patients died
• Deaths ‘due to’ AE’s: 1/250 admissions



                        © May 11, 2006               16
Was Canada any
    better?
Canadian study methods

1. Hospital Selection
2. Patient Chart Selection
3. Two stage Chart Review
  a) Initial screening by nurses
  b) Detailed review by physicians
4. Data Analysis



                     © May 11, 2006   18
1. Hospital Selection
• Sampled: acute care hospitals in the 5
  participating provinces, with at least 1,500
  separations in 2002
• 20 hospitals randomly selected – 1
  teaching, 1 large and two small in each of
  5 provinces




                   © May 11, 2006           19
2. Chart Selection
• Random sample of patient hospitalizations
  (230 for large and teaching and 142 for
  small plus 10% oversample) for the fiscal
  year 2000
• Included all hospitalizations for patients
  over 18 years with a > 24 hours stay (or
  died within 24 hours of admission)
• Hospitalizations with a most responsible
  diagnosis related to obstetrics or
  psychiatry were excluded
                  © May 11, 2006          20
3. Chart Review
• Two-stage retrospective chart review,
  involving trained nurse & physician reviewers
• Stage 1: using explicit criteria, nurse
  reviewers flagged patient records that MAY
  have had an adverse event
• Stage 2: using explicit criteria, physician
  reviewers determined if an adverse event
  occurred – and using judgment assessed the
  degree of preventability


                     © May 11, 2006               21
a) First Stage Chart Review
• Nurse reviews based on 18 “triggers”
• Triggers included (partial list):
  –   Unplanned admission before index admission
  –   Unplanned readmission after discharge from index admission
  –   Hospital incurred patient injury
  –   Adverse drug reaction
  –   Unplanned transfer from general care to intensive care
  –   Unplanned return to OR
  –   Development of neurological deficit not present on admission
  –   Unexpected death




                            © May 11, 2006                       22
b) Second Stage Chart Review
• Records positive on initial trigger(s)
  reviewed in depth by physicians for adverse
  events
• 3 part definition of adverse event
  – Was there an unintended injury or
    complication?
  – If so, did it result in disability, death or
    prolonged hospital stay?
  – If so, was it caused by health care
    management?

                        © May 11, 2006             23
© May 11, 2006   24
Results
The review process
Figure 1.

                                                          4164 medical records
                                                                sampled




                                                                                                            388 not eligible for
                                                          3776 initial screening
                                                                                                             inclusion (note 1.)

Stage 1


                        40.8%                                3745 eligible for                                    31
                                                              full screening                           inadequate documentation




                                                            1527 positive for                                     2218
                                                            screening criteria                       negative for screening criteria
Stage 2




                    1 inadequate                                                                             14 MD unable to
                                                           1512 MDs Reviews
                   documentation                                                                               access chart



          Note 1: 388 not eligible for inclusion: Less than 24 hour stay (n=261); Obstetrics (n=56); Transfer in from other hospital (n=48);
          Cardiac arrest on arrival with subsequent death (n=3); Rehab or Respite care (n=2); Psychiatric (n=2); Unable to determine (n=16).


                                                       © May 11, 2006                                                                          26
Defining the AEs
• 1133 injuries or complications in 858
  hospitalizations
• 401 (47%) resulted in death, disability at the time
  of discharge or prolonged hospitalization
• 255 hospitalizations had one or more of these that
  rated 4 or higher on the 6-point causation scale
• The total number of AEs was 289 and twenty-
  seven (10.6%) of the hospitalizations with AEs had
  more than one AE
• After weighting for the sample frame, the
  overall AE rate was 7.5% [CI 5.7 -9.3]


                      © May 11, 2006             27
Adverse Events and Preventability
By Hospital Type
                                     Hospital Type

                         Small           Large       Teach   Total

Charts sampled           1431            1160        1154    3745
Number charts with AE     73              68         114     255




                        © May 11, 2006                        28
Two Stage Weighting
                                     Hospital Type

                         Small           Large        Teach   Total

Charts sampled           1431             1160        1154     3745

Number charts with AE     73              68           114     255

Weighted AE rate        5.60%            6.40%       10.90%   7.50%




                        © May 11, 2006                          29
Weights applied to the 95%
confidence intervals
                                      Hospital Type

                          Small           Large          Teach          Total

Charts sampled             1431           1160           1154           3745

Number charts with AE       73             68             114           255

Weighted AE rate          5.60%           6.40%         10.90%         7.50%

Weighted 95% CI         (2.9 - 8.2)   (5.1 - 7.7)     (7.0 - 14.8)   (5.7 - 9.3)




                         © May 11, 2006                                   30
Adjustment for co-morbidities
plus age and sex
                                       Hospital Type

                           Small            Large          Teach          Total

Charts sampled             1431             1160            1154          3745

Number charts with AE        73               68            114            255

Weighted AE rate          5.60%            6.40%          10.90%         7.50%

Weighted 95% CI          (2.9 - 8.2)      (5.1 - 7.7)    (7.0 - 14.8)   (5.7 - 9.3)

Adjusted AE rate         5.20%            6.00%          10.30%           n.a.
Adjusted 95% CI         (4.0 - 6.6)    (4.6 - 7.7)      (8.3 - 12.9)        -




                         © May 11, 2006                                     31
Preventability By Hospital Type
                                              Hospital Type

                                  Small           Large         Teach           Total

Charts sampled                    1431            1160           1154           3745

n charts with AE                    73              68           114             255

Weighted AE rate                 5.60%           6.40%          10.90%         7.50%

Weighted 95% CI                 (2.9 - 8.2)     (5.1 - 7.7)   (7.0 - 14.8)    (5.7 - 9.3)

Adjusted AE rate                 5.20%           6.00%          10.30%           n.a.

Adjusted 95% CI                 (4.0 - 6.6)     (4.6 - 7.7)   (8.3 - 12.9)         -

Number Preventable AE              42              28             36            106
Weighted Preventable AE rate    3.30%           2.50%          3.30%          2.80%
Weighted 95% CI                (1.5 -5.1)     (1.7 - 3.3)     (1.8 - 4.8)    (2.0 - 3.6)


                               © May 11, 2006                                     32
Virtually certain evidence of
preventability (examples)
3. Admission because of severe anemia. The
  anemia had been documented in previous
  admission but not investigated fully, which
  resulted in delayed diagnosis of colorectal
  carcinoma
5. Clostridium difficile colitis following
  antibiotic therapy. Patient did not receive
  sufficient volume expansion, which led to
  acute renal failure and death

                   © May 11, 2006          33
Virtually no evidence of
preventability
150. Abdominal pain and fever following
  elective surgical procedure. Patient
  readmitted for antibiotic treatment
151. Acute complications following
  angioplasty with stent resulted in repeat
  angiography (x2), repeat angioplasty (x1)
  and prolonged hospital stay


                   © May 11, 2006         34
Disabilities and Death
• 65% of AEs: either no disability or minimal
  and moderate impairment with recovery
  within 6 months
• 40 patients who had a total of 46 AEs died
• 1.6% [CI =0.9 to 2.2%]: died = 1 / 165
  admissions



                    © May 11, 2006          35
Length of stay
• Patients experiencing AEs have longer stays in
  hospitals
   – Teaching hospitals 11 days versus 5 days (medians)
   – Large 8 days vs 5
   – Small 6 vs 4 for those with none
• Physician reviewers using professional judgement
  estimated that the 255 patients with AEs required
  an additional 1521 days in hospital directly related
  to their adverse event

                        © May 11, 2006                36
Timing of AE




          © May 11, 2006   37
Other Key Findings
• Omissions in medicine AEs (the failure to carry out
  necessary diagnosis or treatment) were more
  common (57.1%), than adverse events resulting
  from errors of commission (42.9%)
• Adverse events from both types of errors are
  roughly equal in surgery
• Average age of patients experiencing an adverse
  event was 64.9 years (SD=16.7) compared to 62.0
  (SD=18.4) for those who did not
• No difference between female and male patients

                      © May 11, 2006             38
Extrapolation
• In fiscal year 2000 between 141,250 and
  232,250 acute care hospitalizations could
  have been associated with an AE out of
  2,500,000 similar hospitalizations in Canada
• The number of preventable deaths could
  have ranged from 9,250 to 23,750



                   © May 11, 2006          39
Extrapolation
Deaths associated with AE:
•   USA:         1 death per 200 admissions
•   Australia:   1 / 250
•   Canada:      1 / 165
•   Spain:       ?



                     © May 11, 2006           40
Limitations
• Retrospective chart review: hindsight bias
• Budget constraints: only 20 hospitals in five provinces
• Very small or remote hospitals were not studied
• Only adult patients in acute care general hospital
• Excluded those with a most responsible diagnosis in
  obstetrics or psychiatry
• Our reliability measurement: only moderate agreement
  among physicians in assessing injury, preventability and
  the contribution of healthcare management to AE
• The additional length of stay attributed to the AE was
  based on the physician’s professional opinion and
  interpretation of the patient chart



                         © May 11, 2006                 41
Was Canada any
    better?
 Nope – we are all in the
      same boat!
Incidence Estimates from Other Chart
Review Studies
                                  Incidence
                                    of AE
  Country    N         Year                     Preventable?
 USA (Utah 15,000      2000              2.9%        -
 & Colorado)
 England       1,014   2001          11.7%          50%

 New                   2004          12.9%          37%
               6,579
 Zealand
 Denmark       1,097   2001              9.0%      40.4%


                        © May 11, 2006                     43
Incidence Estimates from Other Chart
Review Studies
                                 Incidence
                                   of AE
  Country    N         Year                  Preventable?
 USA (Utah 15,000      2000          2.9%         -
 & Colorado)
 England       1,014   2001         11.7%        50%

 New                   2004         12.9%        37%
               6,579
 Zealand
 Denmark       1,097   2001          9.0%       40.4%

 Canada        3,745   2002          7.5%        39%

                        © May 11, 2006                  44
Why did we do a Canadian study?
• A critical element for accelerating safety
  work is that a country has its own data
• The number is an underestimate and so the
  method cannot be used as an outcome
  measure for safety
• Modeling can be carried out to delineate:
  – Possible areas for improvement
  – High hazard situations
  – Management opportunities

                    © May 11, 2006       45
When safety nets fail….
                             CT not
  CT report                  read,                  Unaware CT
  non-verbal                 no F/U                 done

               CT Report              CT report
               missed                 ignored




Radiology   Residents      Staff      Consultants    Family Doctor
………………………………………………………………………..
             © May 11, 2006 46
….patients are harmed
Especially, if:
a. Patients remain uninformed
b. Too trusting (“They would call if
   something was seen on the
   XRay…”)




                 © May 11, 2006        47
Acceptable risk
                                           Dangerous           Regulated             Ultra-safe
                                           (>1/1000)                                 (<1/100K)
                            100,000
Total Lives Lost per year




                             10,000

                                                                         “Acceptable public risk”
                              1,000


                               100

                                10


                                 1    10        100    1,000    10,000     100,000   1,000,000   10,000,000

                                           Number of encounters for each fatality
                                                       © May 11, 2006                               48
Risky activities (Canada)
                                           Dangerous                 Regulated                 Ultra-safe
                                           (>1/1000)                                           (<1/100K)
                            100,000
Total Lives Lost per year




                                             Hospitalisation
                             10,000
                                                                  Driving
                                                         Offshore rig
                              1,000
                                                                                              Commercial airlines
                                                                      Coal Mining
                                                      timber                           Firearms
                               100                             truckers
                                                                     construction
                                                        Rock
                                10                                              Bungee Jumping
                                                        Climbing
                                                                                    Scuba diving
                                                        for 25 hrs

                                 1    10        100       1,000        10,000       100,000   1,000,000    10,000,000

                                           Number of encounters for each fatality
                                                       © May 11, 2006                                         49
Unacceptable risk
15,000 deaths/yr
                                           Dangerous             Regulated             Ultra-safe
                                           (>1/1000)                                   (<1/100K)
                            100,000
Total Lives Lost per year




                                                                                               1/165 risk
                                             Hospitalisation
                             10,000                                                            of death

                              1,000
                                                                           “Acceptable public risk”

                               100

                                10


                                 1    10        100      1,000    10,000     100,000   1,000,000   10,000,000

                                           Number of encounters for each fatality
                                                       © May 11, 2006                                 50
Our task
                                           Dangerous             Regulated             Ultra-safe
                                           (>1/1000)                                   (<1/100K)
                            100,000
Total Lives Lost per year




                                             Hospitalisation
                             10,000


                              1,000
                                                                           “Acceptable public risk”

                               100

                                10


                                 1    10        100      1,000    10,000     100,000   1,000,000   10,000,000

                                           Number of encounters for each fatality
                                                       © May 11, 2006                                 51
Our task
                                           Dangerous             Regulated                 Ultra-safe
                                           (>1/1000)                                       (<1/100K)
                            100,000
                                                               Hospitalisation
Total Lives Lost per year




                             10,000


                              1,000
                                                                             “Acceptable public risk”

                               100

                                10


                                 1    10        100    1,000       10,000        100,000   1,000,000   10,000,000

                                           Number of encounters for each fatality
                                                       © May 11, 2006                                     52
Our task
                                           Dangerous           Regulated             Ultra-safe
                                           (>1/1000)                                 (<1/100K)
                            100,000
Total Lives Lost per year




                                                                                           Hospitalisation
                             10,000


                              1,000
                                                                         “Acceptable public risk”

                               100

                                10


                                 1    10        100    1,000    10,000     100,000   1,000,000   10,000,000

                                           Number of encounters for each fatality
                                                       © May 11, 2006                               53
Study leads to change
• By examining the individual stories of the
  AEs we determined that that the most
  common are:
  – failures in diagnosis
  – prescription of contraindicated drugs
  – incorrect management of organ failure




                     © May 11, 2006            54
• Pan-Canadian initiative
• Modeled after US 100.000 lives Campaign
• 3 nodes; Western, Ontario, Eastern
• National Steering Committee
• Secretariat - Canadian Patient Safety
  Institute
• National Working Groups:
   – Measurement, Education, Communication

                 © May 11, 2006        55
• Deployment of Rapid Response Teams
  • Delivery of reliable, evidence based care for acute
    myocardial infarctions
  • Prevention of ADEs through Medication
    Reconciliation
  • Prevention of Central Line Infections
  • Prevention of Surgical Site Infections
  • Prevention of Ventilator - Associated Pneumonia




                         © May 11, 2006                     56
Safer Healthcare Now!                              Calgary, Alberta
Western Node:
 •    BC Patient Safety Taskforce
 •    Canadian Patient Safety Institute
 •    Health Quality Council of Alberta
 •    Manitoba Patient Safety Institute


 Lead Planning Group:
 Dr. Ward Flemons
 Dr. Ross Baker
 Marlies van Dijk
 Dr. Peter Norton


                               © May 11, 2006            57
Safer Healthcare Now!                           Calgary, Alberta
Safer Healthcare Now! Enrollment




       © May 11, 2006        58
© May 11, 2006   59
© May 11, 2006   60
© May 11, 2006   61
© May 11, 2006   62
© May 11, 2006   63
© May 11, 2006   64
© May 11, 2006   65
Can
                                 change
Tremendous prescribing variation that




                © May 11, 2006                        66
               Health Quality Council of Saskatchewan, 2004
How does Canada compare?
• 2004 Commonwealth Fund International
  Health Policy Survey in Australia, Canada,
  New Zealand, the United Kingdom, and the
  United States
• Adults
• 1400 per country and 3061 in the UK

         Schoen C, et. al. Primary care and health system performance:
         adults' experiences in five countries. Health Aff (Millwood). 2004
         Jul-Dec;Suppl Web Exclusives:W4-487-503.

                          © May 11, 2006                            67
When you need care or treatment, how often does
                                     the doctor tell you about treatment choices and
                                     ask for your ideas/opinions?
                                     60%
% saying sometimes/rarely or never




                                     50%

                                     40%


                                     30%

                                     20%


                                     10%

                                     0%
                                           Australia   Canada     New Zealand    United   United States
                                                           © May 11, 2006                     68
                                                                                Kingdom
Last time you were sick or needed medical
            attention, how quickly can you get an appointment
            to see a doctor?
                          60%


                          50%
% saying 2 or more days




                          40%


                          30%


                          20%


                          10%


                          0%
                                Australia   Canada     New Zealand    United   United States
                                                 © May 11, 2006                      69
                                                                     Kingdom
Rank 1 is best, 5 is worst              Slide from Don Berwick August 2005

                                       New
                 Australia Canada                     UK            US
                                      Zealand

                  2.5       4           2.5            1             5
Patient Safety
  Patient-
                   2        3             1            5             4
Centeredness

                   2        5             1            4             3
 Timeliness

                   1        4             2            3             5
  Efficiency

                  4.5      2.5          2.5            1           4.5
Effectiveness

                   2        4             3            1             5
   Equity

                              © May 11, 2006                          70
Conclusions: “win-win”
• The study provides a starting point for understanding the
  incidence of AEs and the resulting burden of injury

• Additional work is needed to explore the types of AEs and
  their contributing factors.

• Efforts to improve medication safety and surgery are likely
  to play an important role in improving patient safety in
  Canadian hospitals

• Additional research is needed on the incidence and types
  of AEs beyond the acute care hospital setting



                            © May 11, 2006                    71
philip.hebert@sunnybrook.ca
Thanks to Peter Norton, Ross Baker, Ed Etchells




                        © May 11, 2006            72

Mais conteúdo relacionado

Mais procurados

KAIMRC 2014 Oral Presentation: Are Pathways Effective in Acute Kidney Injury
KAIMRC 2014 Oral Presentation: Are Pathways Effective in Acute Kidney InjuryKAIMRC 2014 Oral Presentation: Are Pathways Effective in Acute Kidney Injury
KAIMRC 2014 Oral Presentation: Are Pathways Effective in Acute Kidney Injurymaryam_kk
 
Cardiology Journal club
Cardiology Journal clubCardiology Journal club
Cardiology Journal clubPRAVEEN GUPTA
 
Effect of rosuvastatin on rheumatoid arthritis clinical disease activity inde...
Effect of rosuvastatin on rheumatoid arthritis clinical disease activity inde...Effect of rosuvastatin on rheumatoid arthritis clinical disease activity inde...
Effect of rosuvastatin on rheumatoid arthritis clinical disease activity inde...Alexander Decker
 
Presentation reducing readmissions 2019
Presentation  reducing  readmissions 2019 Presentation  reducing  readmissions 2019
Presentation reducing readmissions 2019 Imad Hassan
 
APPLY MACHINE LEARNING METHODS TO PREDICT FAILURE OF GLAUCOMA DRAINAGE
APPLY MACHINE LEARNING METHODS TO PREDICT FAILURE OF GLAUCOMA DRAINAGEAPPLY MACHINE LEARNING METHODS TO PREDICT FAILURE OF GLAUCOMA DRAINAGE
APPLY MACHINE LEARNING METHODS TO PREDICT FAILURE OF GLAUCOMA DRAINAGEIJDKP
 
Recent cardiology updates ehrs2018
Recent cardiology updates ehrs2018Recent cardiology updates ehrs2018
Recent cardiology updates ehrs2018hospital
 
L’indagine urodinamica prima della chirurgia per IUS PRO
L’indagine urodinamica prima della chirurgia per IUS PROL’indagine urodinamica prima della chirurgia per IUS PRO
L’indagine urodinamica prima della chirurgia per IUS PROGLUP2010
 
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053BartsMSBlog
 
Actrims 2016 oratorio poster montalban_p023 (1)
Actrims 2016 oratorio poster montalban_p023 (1)Actrims 2016 oratorio poster montalban_p023 (1)
Actrims 2016 oratorio poster montalban_p023 (1)BartsMSBlog
 
Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...
Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...
Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...Institute for Clinical Research (ICR)
 
July 2016 penetrating ocular trauma
July 2016  penetrating ocular traumaJuly 2016  penetrating ocular trauma
July 2016 penetrating ocular traumaVinitkumar MJ
 
Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...
Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...
Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...Institute for Clinical Research (ICR)
 
Breaking the barriers in the management of neovascular AMD
Breaking the barriers in the management of neovascular AMDBreaking the barriers in the management of neovascular AMD
Breaking the barriers in the management of neovascular AMDAjayDudani1
 
ADAD forum webinar May 2012
ADAD forum webinar May 2012ADAD forum webinar May 2012
ADAD forum webinar May 2012Marty Reiswig
 

Mais procurados (20)

National Health Policy Forum (3/25/11)
National Health Policy Forum (3/25/11)National Health Policy Forum (3/25/11)
National Health Policy Forum (3/25/11)
 
Q3 2009 Earning Report of Johnson & Johnson
Q3 2009 Earning Report of Johnson & JohnsonQ3 2009 Earning Report of Johnson & Johnson
Q3 2009 Earning Report of Johnson & Johnson
 
KAIMRC 2014 Oral Presentation: Are Pathways Effective in Acute Kidney Injury
KAIMRC 2014 Oral Presentation: Are Pathways Effective in Acute Kidney InjuryKAIMRC 2014 Oral Presentation: Are Pathways Effective in Acute Kidney Injury
KAIMRC 2014 Oral Presentation: Are Pathways Effective in Acute Kidney Injury
 
Cardiology Journal club
Cardiology Journal clubCardiology Journal club
Cardiology Journal club
 
Effect of rosuvastatin on rheumatoid arthritis clinical disease activity inde...
Effect of rosuvastatin on rheumatoid arthritis clinical disease activity inde...Effect of rosuvastatin on rheumatoid arthritis clinical disease activity inde...
Effect of rosuvastatin on rheumatoid arthritis clinical disease activity inde...
 
Presentation reducing readmissions 2019
Presentation  reducing  readmissions 2019 Presentation  reducing  readmissions 2019
Presentation reducing readmissions 2019
 
APPLY MACHINE LEARNING METHODS TO PREDICT FAILURE OF GLAUCOMA DRAINAGE
APPLY MACHINE LEARNING METHODS TO PREDICT FAILURE OF GLAUCOMA DRAINAGEAPPLY MACHINE LEARNING METHODS TO PREDICT FAILURE OF GLAUCOMA DRAINAGE
APPLY MACHINE LEARNING METHODS TO PREDICT FAILURE OF GLAUCOMA DRAINAGE
 
Recent cardiology updates ehrs2018
Recent cardiology updates ehrs2018Recent cardiology updates ehrs2018
Recent cardiology updates ehrs2018
 
L’indagine urodinamica prima della chirurgia per IUS PRO
L’indagine urodinamica prima della chirurgia per IUS PROL’indagine urodinamica prima della chirurgia per IUS PRO
L’indagine urodinamica prima della chirurgia per IUS PRO
 
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053
 
Actrims 2016 oratorio poster montalban_p023 (1)
Actrims 2016 oratorio poster montalban_p023 (1)Actrims 2016 oratorio poster montalban_p023 (1)
Actrims 2016 oratorio poster montalban_p023 (1)
 
Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...
Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...
Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...
 
Nolan J - AIMRADIAL 2014 - Heparin is better
Nolan J - AIMRADIAL 2014 - Heparin is betterNolan J - AIMRADIAL 2014 - Heparin is better
Nolan J - AIMRADIAL 2014 - Heparin is better
 
July 2016 penetrating ocular trauma
July 2016  penetrating ocular traumaJuly 2016  penetrating ocular trauma
July 2016 penetrating ocular trauma
 
Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...
Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...
Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...
 
Breaking the barriers in the management of neovascular AMD
Breaking the barriers in the management of neovascular AMDBreaking the barriers in the management of neovascular AMD
Breaking the barriers in the management of neovascular AMD
 
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervationPancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
 
ADAD forum webinar May 2012
ADAD forum webinar May 2012ADAD forum webinar May 2012
ADAD forum webinar May 2012
 
1645 ainsworth
1645 ainsworth1645 ainsworth
1645 ainsworth
 
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen testKoutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
Koutouzis M - AIMRADIAL 2015 - Transradial and negative Allen test
 

Semelhante a The Canadian Adverse Events Study: The Incidence of Adverse Events among hospital patients in Canada

ovulation induction protocols update 2014
ovulation induction protocols update 2014ovulation induction protocols update 2014
ovulation induction protocols update 2014Hesham Al-Inany
 
Situational analysis of diabetic services in West Bank, Retina Today conferen...
Situational analysis of diabetic services in West Bank, Retina Today conferen...Situational analysis of diabetic services in West Bank, Retina Today conferen...
Situational analysis of diabetic services in West Bank, Retina Today conferen...njsargent
 
Session 6C - MHS Vision
Session 6C - MHS VisionSession 6C - MHS Vision
Session 6C - MHS VisionMedXellence
 
Status Epilepticus
Status EpilepticusStatus Epilepticus
Status EpilepticusNHS
 
Predictors of Symptom Worsening or Improvement using Remote Patient Reported ...
Predictors of Symptom Worsening or Improvement using Remote Patient Reported ...Predictors of Symptom Worsening or Improvement using Remote Patient Reported ...
Predictors of Symptom Worsening or Improvement using Remote Patient Reported ...Carevive
 
Closing the loop_on_referral_management_processes_circo
Closing the loop_on_referral_management_processes_circoClosing the loop_on_referral_management_processes_circo
Closing the loop_on_referral_management_processes_circoAmy Stiner, RN, MBA, MPA
 
HANDOUT_MTP015_Art_Physical_Diagnosis.pdf
HANDOUT_MTP015_Art_Physical_Diagnosis.pdfHANDOUT_MTP015_Art_Physical_Diagnosis.pdf
HANDOUT_MTP015_Art_Physical_Diagnosis.pdfJuan491341
 
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020IACTSWeb
 
Atlanta Classification.ppt
Atlanta Classification.pptAtlanta Classification.ppt
Atlanta Classification.pptHemanta Pun
 
Neoadjuvant Chemotherapy in muscle invasive bladder cancer: The Standard of ...
Neoadjuvant Chemotherapy in muscle invasive bladder cancer:The Standard of ...Neoadjuvant Chemotherapy in muscle invasive bladder cancer:The Standard of ...
Neoadjuvant Chemotherapy in muscle invasive bladder cancer: The Standard of ...Diaa A. Hameed
 
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...Claudio Melloni
 
Importanza anestesista in oftalmologia 2013;role of the anesthesiologists in ...
Importanza anestesista in oftalmologia 2013;role of the anesthesiologists in ...Importanza anestesista in oftalmologia 2013;role of the anesthesiologists in ...
Importanza anestesista in oftalmologia 2013;role of the anesthesiologists in ...Claudio Melloni
 
adrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.ppt
adrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.pptadrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.ppt
adrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.pptYelsingReyes
 
Stoppen Met Antidepressiva
Stoppen Met AntidepressivaStoppen Met Antidepressiva
Stoppen Met AntidepressivaRobHeerdink
 

Semelhante a The Canadian Adverse Events Study: The Incidence of Adverse Events among hospital patients in Canada (20)

Appendix by drdamodhar.m.v
Appendix by drdamodhar.m.vAppendix by drdamodhar.m.v
Appendix by drdamodhar.m.v
 
ovulation induction protocols update 2014
ovulation induction protocols update 2014ovulation induction protocols update 2014
ovulation induction protocols update 2014
 
Situational analysis of diabetic services in West Bank, Retina Today conferen...
Situational analysis of diabetic services in West Bank, Retina Today conferen...Situational analysis of diabetic services in West Bank, Retina Today conferen...
Situational analysis of diabetic services in West Bank, Retina Today conferen...
 
Session 6C - MHS Vision
Session 6C - MHS VisionSession 6C - MHS Vision
Session 6C - MHS Vision
 
Status Epilepticus
Status EpilepticusStatus Epilepticus
Status Epilepticus
 
Predictors of Symptom Worsening or Improvement using Remote Patient Reported ...
Predictors of Symptom Worsening or Improvement using Remote Patient Reported ...Predictors of Symptom Worsening or Improvement using Remote Patient Reported ...
Predictors of Symptom Worsening or Improvement using Remote Patient Reported ...
 
1 Hassan
1  Hassan1  Hassan
1 Hassan
 
Closing the loop_on_referral_management_processes_circo
Closing the loop_on_referral_management_processes_circoClosing the loop_on_referral_management_processes_circo
Closing the loop_on_referral_management_processes_circo
 
HANDOUT_MTP015_Art_Physical_Diagnosis.pdf
HANDOUT_MTP015_Art_Physical_Diagnosis.pdfHANDOUT_MTP015_Art_Physical_Diagnosis.pdf
HANDOUT_MTP015_Art_Physical_Diagnosis.pdf
 
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
 
27.SAR 2014
27.SAR 201427.SAR 2014
27.SAR 2014
 
Geriatric oncology 2019
Geriatric oncology 2019Geriatric oncology 2019
Geriatric oncology 2019
 
Atlanta Classification.ppt
Atlanta Classification.pptAtlanta Classification.ppt
Atlanta Classification.ppt
 
Neoadjuvant Chemotherapy in muscle invasive bladder cancer: The Standard of ...
Neoadjuvant Chemotherapy in muscle invasive bladder cancer:The Standard of ...Neoadjuvant Chemotherapy in muscle invasive bladder cancer:The Standard of ...
Neoadjuvant Chemotherapy in muscle invasive bladder cancer: The Standard of ...
 
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
Importanza anestesista in oftalmologia 2013/IMportance of the anesthesiologis...
 
Lab Guide
Lab GuideLab Guide
Lab Guide
 
Importanza anestesista in oftalmologia 2013;role of the anesthesiologists in ...
Importanza anestesista in oftalmologia 2013;role of the anesthesiologists in ...Importanza anestesista in oftalmologia 2013;role of the anesthesiologists in ...
Importanza anestesista in oftalmologia 2013;role of the anesthesiologists in ...
 
Jose r lopez minguez novedades cierre laa
Jose r lopez minguez novedades cierre laaJose r lopez minguez novedades cierre laa
Jose r lopez minguez novedades cierre laa
 
adrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.ppt
adrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.pptadrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.ppt
adrenal-incidentaloma-presentation-20121-Seb-Aspinall-rec-5-2-13.ppt
 
Stoppen Met Antidepressiva
Stoppen Met AntidepressivaStoppen Met Antidepressiva
Stoppen Met Antidepressiva
 

Mais de Plan de Calidad para el SNS

Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...
Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...
Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...Plan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...Plan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...Plan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...Plan de Calidad para el SNS
 
Experiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerExperiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerPlan de Calidad para el SNS
 
Experiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerExperiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerPlan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...Plan de Calidad para el SNS
 
Experiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerExperiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerPlan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...Plan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...Plan de Calidad para el SNS
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...Plan de Calidad para el SNS
 
The power of lifestyle interventions to prevent cardiovascular diseases
The power of lifestyle interventions to prevent cardiovascular diseasesThe power of lifestyle interventions to prevent cardiovascular diseases
The power of lifestyle interventions to prevent cardiovascular diseasesPlan de Calidad para el SNS
 
Risk Assessment and Management of Cardiovascular Diseases - an English Approach
Risk Assessment and Management of Cardiovascular Diseases - an English ApproachRisk Assessment and Management of Cardiovascular Diseases - an English Approach
Risk Assessment and Management of Cardiovascular Diseases - an English ApproachPlan de Calidad para el SNS
 
Cardiovascular disease inequalities: causes and consequences
Cardiovascular disease inequalities: causes and consequencesCardiovascular disease inequalities: causes and consequences
Cardiovascular disease inequalities: causes and consequencesPlan de Calidad para el SNS
 
Addressing cardiovascular disease at EU level: tangible plans for the future
Addressing cardiovascular disease at EU level: tangible plans for the futureAddressing cardiovascular disease at EU level: tangible plans for the future
Addressing cardiovascular disease at EU level: tangible plans for the futurePlan de Calidad para el SNS
 
The impact of eHealth on Healthcare Professionals and Organisations: The Impa...
The impact of eHealth on Healthcare Professionals and Organisations: The Impa...The impact of eHealth on Healthcare Professionals and Organisations: The Impa...
The impact of eHealth on Healthcare Professionals and Organisations: The Impa...Plan de Calidad para el SNS
 

Mais de Plan de Calidad para el SNS (20)

Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...
Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...
Multidisciplinary care: a perspective from diagnosis and treatment of rare ca...
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
Experiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerExperiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncer
 
Experiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerExperiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncer
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
Experiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncerExperiencias y percepción de la atención integral de los pacientes con cáncer
Experiencias y percepción de la atención integral de los pacientes con cáncer
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
La mejor evidencia junto a la mejor organización: el reto de la coordinación ...
 
The power of lifestyle interventions to prevent cardiovascular diseases
The power of lifestyle interventions to prevent cardiovascular diseasesThe power of lifestyle interventions to prevent cardiovascular diseases
The power of lifestyle interventions to prevent cardiovascular diseases
 
Alcohol and chronic diseases: complex relations
Alcohol and chronic diseases: complex relationsAlcohol and chronic diseases: complex relations
Alcohol and chronic diseases: complex relations
 
Risk Assessment and Management of Cardiovascular Diseases - an English Approach
Risk Assessment and Management of Cardiovascular Diseases - an English ApproachRisk Assessment and Management of Cardiovascular Diseases - an English Approach
Risk Assessment and Management of Cardiovascular Diseases - an English Approach
 
Cardiovascular disease inequalities: causes and consequences
Cardiovascular disease inequalities: causes and consequencesCardiovascular disease inequalities: causes and consequences
Cardiovascular disease inequalities: causes and consequences
 
Anti-Smoking policies in Ireland
Anti-Smoking policies in IrelandAnti-Smoking policies in Ireland
Anti-Smoking policies in Ireland
 
Addressing cardiovascular disease at EU level: tangible plans for the future
Addressing cardiovascular disease at EU level: tangible plans for the futureAddressing cardiovascular disease at EU level: tangible plans for the future
Addressing cardiovascular disease at EU level: tangible plans for the future
 
eHealth Reality in North America
eHealth Reality in North AmericaeHealth Reality in North America
eHealth Reality in North America
 
B2B Medical Intermediaries
B2B Medical IntermediariesB2B Medical Intermediaries
B2B Medical Intermediaries
 
The impact of eHealth on Healthcare Professionals and Organisations: The Impa...
The impact of eHealth on Healthcare Professionals and Organisations: The Impa...The impact of eHealth on Healthcare Professionals and Organisations: The Impa...
The impact of eHealth on Healthcare Professionals and Organisations: The Impa...
 

Último

Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 

Último (20)

Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 

The Canadian Adverse Events Study: The Incidence of Adverse Events among hospital patients in Canada

  • 1. G. Ross Baker, Peter G. Norton, Virginia Flintoft, Régis Blais, Adalsteinn Brown, Jafna Cox, Ed Etchells, William A. Ghali, Philip Hébert, Sumit R. Majumdar, Maeve O'Beirne, Luz Palacios-Derflingher, Robert Reid, Sam Sheps, Robyn Tamblyn The Canadian Adverse Events Study: The Incidence Of Adverse Events Among Hospital Patients In Canada Research funded by CIHI and CIHR philip.hebert@sunnybrook.ca May 11, 2006
  • 2. Outline • Our national study • Other studies, briefly • Our methods • Results • Limitations • Implications © May 11, 2006 2
  • 3. First and only national study of incidence of adverse events in Canadian healthcare
  • 4. © May 11, 2006 4
  • 5. British Columbia © May 11, 2006 5
  • 7. Ontario © May 11, 2006 7
  • 8. Québec © May 11, 2006 8
  • 9. Nova Scotia © May 11, 2006 9
  • 10. Study Reviewers Nova Scotia: Brenda Brownell, Dr. Tom Casey, Dr. John Fraser, Kelly Goudey, Dr. Ron Gregor, Celeste Latter, and Dr. Allan Shlossberg Québec : Dr. Edouard Bastien; Dr. Richard Clermont, Evelyne Jean, Cécile Lavoie, Dr. André Rioux. Julie Robindaine, and Daphney St- Germain Ontario: Dr. Ed Etchells, Virginia Flintoft, Wilhelmine Jones, Dr. Peter Kopplin, Dr. David MacPherson, and Elaine Thiel Alberta: Fatima Chatur, Dr. Leslie Cunning, Dr. Peter Hamilton, Dr. Narmin Kassam and Carolyn Nilsson British Columbia: Karen Cardiff, Dr. Robert Crossland, Dr. Iain Mackie, Cheryl Marr, Dr. Jacob Meyerhoff, Eva Somogyi and Dr. Robert Wakefield © May 11, 2006 10
  • 11. Study Goals 1. To identify the incidence of adverse events in a representative sample of Canadian hospitals 2. To compare the incidence between medical and surgical patients and between different types of hospitals 3. To compare the incidence to similar studies in England, Australia, New Zealand and elsewhere © May 11, 2006 11
  • 12. Example • 77 year-old male with a long history of renal stones was seen in ER with hematuria • CT revealed renal stones AND a large renal mass with nodules in lungs • CT done 1 year previously revealed a smaller renal mass and no nodules • His urologist had seen that CT report but missed the conclusion as did several others © May 11, 2006 12
  • 13. Example • An adverse event and (likely) preventable (ie., potentially curable last year, now not) • Caused by an omission…. – If only, the radiologist had called – If only, the resident had seen the XRay – If only, the staffman had read the report – If only, other urologists had read the report – If only the patient had complained… © May 11, 2006 13
  • 14. Not at all unique
  • 15. Harvard Medical Practice Study NEJM Feb 1991 • Review of 30,121 randomly selected medical records from 51 NY acute care hospitals for patients in 1984 • Purpose: incidence of medical negligence • Adverse events occurred in 4% of hospitalizations; 28% of these were due to negligence (=1% hospitalizations) • 71% of AE’s gave rise to disabilities < 6 months • 14% resulted in patient’s death: 1/200 admissions! © May 11, 2006 15
  • 16. Quality In Australian Health Care Study Med J Australia Nov 1995 • 14,000 admissions to 28 hospitals in New South Wales and South Australia • Used HMPS methods, but redefined AE • 17% of admissions had an adverse event • 50% preventable. • 77% lasted < 12 months; • 5% of the patients died • Deaths ‘due to’ AE’s: 1/250 admissions © May 11, 2006 16
  • 17. Was Canada any better?
  • 18. Canadian study methods 1. Hospital Selection 2. Patient Chart Selection 3. Two stage Chart Review a) Initial screening by nurses b) Detailed review by physicians 4. Data Analysis © May 11, 2006 18
  • 19. 1. Hospital Selection • Sampled: acute care hospitals in the 5 participating provinces, with at least 1,500 separations in 2002 • 20 hospitals randomly selected – 1 teaching, 1 large and two small in each of 5 provinces © May 11, 2006 19
  • 20. 2. Chart Selection • Random sample of patient hospitalizations (230 for large and teaching and 142 for small plus 10% oversample) for the fiscal year 2000 • Included all hospitalizations for patients over 18 years with a > 24 hours stay (or died within 24 hours of admission) • Hospitalizations with a most responsible diagnosis related to obstetrics or psychiatry were excluded © May 11, 2006 20
  • 21. 3. Chart Review • Two-stage retrospective chart review, involving trained nurse & physician reviewers • Stage 1: using explicit criteria, nurse reviewers flagged patient records that MAY have had an adverse event • Stage 2: using explicit criteria, physician reviewers determined if an adverse event occurred – and using judgment assessed the degree of preventability © May 11, 2006 21
  • 22. a) First Stage Chart Review • Nurse reviews based on 18 “triggers” • Triggers included (partial list): – Unplanned admission before index admission – Unplanned readmission after discharge from index admission – Hospital incurred patient injury – Adverse drug reaction – Unplanned transfer from general care to intensive care – Unplanned return to OR – Development of neurological deficit not present on admission – Unexpected death © May 11, 2006 22
  • 23. b) Second Stage Chart Review • Records positive on initial trigger(s) reviewed in depth by physicians for adverse events • 3 part definition of adverse event – Was there an unintended injury or complication? – If so, did it result in disability, death or prolonged hospital stay? – If so, was it caused by health care management? © May 11, 2006 23
  • 24. © May 11, 2006 24
  • 26. The review process Figure 1. 4164 medical records sampled 388 not eligible for 3776 initial screening inclusion (note 1.) Stage 1 40.8% 3745 eligible for 31 full screening inadequate documentation 1527 positive for 2218 screening criteria negative for screening criteria Stage 2 1 inadequate 14 MD unable to 1512 MDs Reviews documentation access chart Note 1: 388 not eligible for inclusion: Less than 24 hour stay (n=261); Obstetrics (n=56); Transfer in from other hospital (n=48); Cardiac arrest on arrival with subsequent death (n=3); Rehab or Respite care (n=2); Psychiatric (n=2); Unable to determine (n=16). © May 11, 2006 26
  • 27. Defining the AEs • 1133 injuries or complications in 858 hospitalizations • 401 (47%) resulted in death, disability at the time of discharge or prolonged hospitalization • 255 hospitalizations had one or more of these that rated 4 or higher on the 6-point causation scale • The total number of AEs was 289 and twenty- seven (10.6%) of the hospitalizations with AEs had more than one AE • After weighting for the sample frame, the overall AE rate was 7.5% [CI 5.7 -9.3] © May 11, 2006 27
  • 28. Adverse Events and Preventability By Hospital Type Hospital Type Small Large Teach Total Charts sampled 1431 1160 1154 3745 Number charts with AE 73 68 114 255 © May 11, 2006 28
  • 29. Two Stage Weighting Hospital Type Small Large Teach Total Charts sampled 1431 1160 1154 3745 Number charts with AE 73 68 114 255 Weighted AE rate 5.60% 6.40% 10.90% 7.50% © May 11, 2006 29
  • 30. Weights applied to the 95% confidence intervals Hospital Type Small Large Teach Total Charts sampled 1431 1160 1154 3745 Number charts with AE 73 68 114 255 Weighted AE rate 5.60% 6.40% 10.90% 7.50% Weighted 95% CI (2.9 - 8.2) (5.1 - 7.7) (7.0 - 14.8) (5.7 - 9.3) © May 11, 2006 30
  • 31. Adjustment for co-morbidities plus age and sex Hospital Type Small Large Teach Total Charts sampled 1431 1160 1154 3745 Number charts with AE 73 68 114 255 Weighted AE rate 5.60% 6.40% 10.90% 7.50% Weighted 95% CI (2.9 - 8.2) (5.1 - 7.7) (7.0 - 14.8) (5.7 - 9.3) Adjusted AE rate 5.20% 6.00% 10.30% n.a. Adjusted 95% CI (4.0 - 6.6) (4.6 - 7.7) (8.3 - 12.9) - © May 11, 2006 31
  • 32. Preventability By Hospital Type Hospital Type Small Large Teach Total Charts sampled 1431 1160 1154 3745 n charts with AE 73 68 114 255 Weighted AE rate 5.60% 6.40% 10.90% 7.50% Weighted 95% CI (2.9 - 8.2) (5.1 - 7.7) (7.0 - 14.8) (5.7 - 9.3) Adjusted AE rate 5.20% 6.00% 10.30% n.a. Adjusted 95% CI (4.0 - 6.6) (4.6 - 7.7) (8.3 - 12.9) - Number Preventable AE 42 28 36 106 Weighted Preventable AE rate 3.30% 2.50% 3.30% 2.80% Weighted 95% CI (1.5 -5.1) (1.7 - 3.3) (1.8 - 4.8) (2.0 - 3.6) © May 11, 2006 32
  • 33. Virtually certain evidence of preventability (examples) 3. Admission because of severe anemia. The anemia had been documented in previous admission but not investigated fully, which resulted in delayed diagnosis of colorectal carcinoma 5. Clostridium difficile colitis following antibiotic therapy. Patient did not receive sufficient volume expansion, which led to acute renal failure and death © May 11, 2006 33
  • 34. Virtually no evidence of preventability 150. Abdominal pain and fever following elective surgical procedure. Patient readmitted for antibiotic treatment 151. Acute complications following angioplasty with stent resulted in repeat angiography (x2), repeat angioplasty (x1) and prolonged hospital stay © May 11, 2006 34
  • 35. Disabilities and Death • 65% of AEs: either no disability or minimal and moderate impairment with recovery within 6 months • 40 patients who had a total of 46 AEs died • 1.6% [CI =0.9 to 2.2%]: died = 1 / 165 admissions © May 11, 2006 35
  • 36. Length of stay • Patients experiencing AEs have longer stays in hospitals – Teaching hospitals 11 days versus 5 days (medians) – Large 8 days vs 5 – Small 6 vs 4 for those with none • Physician reviewers using professional judgement estimated that the 255 patients with AEs required an additional 1521 days in hospital directly related to their adverse event © May 11, 2006 36
  • 37. Timing of AE © May 11, 2006 37
  • 38. Other Key Findings • Omissions in medicine AEs (the failure to carry out necessary diagnosis or treatment) were more common (57.1%), than adverse events resulting from errors of commission (42.9%) • Adverse events from both types of errors are roughly equal in surgery • Average age of patients experiencing an adverse event was 64.9 years (SD=16.7) compared to 62.0 (SD=18.4) for those who did not • No difference between female and male patients © May 11, 2006 38
  • 39. Extrapolation • In fiscal year 2000 between 141,250 and 232,250 acute care hospitalizations could have been associated with an AE out of 2,500,000 similar hospitalizations in Canada • The number of preventable deaths could have ranged from 9,250 to 23,750 © May 11, 2006 39
  • 40. Extrapolation Deaths associated with AE: • USA: 1 death per 200 admissions • Australia: 1 / 250 • Canada: 1 / 165 • Spain: ? © May 11, 2006 40
  • 41. Limitations • Retrospective chart review: hindsight bias • Budget constraints: only 20 hospitals in five provinces • Very small or remote hospitals were not studied • Only adult patients in acute care general hospital • Excluded those with a most responsible diagnosis in obstetrics or psychiatry • Our reliability measurement: only moderate agreement among physicians in assessing injury, preventability and the contribution of healthcare management to AE • The additional length of stay attributed to the AE was based on the physician’s professional opinion and interpretation of the patient chart © May 11, 2006 41
  • 42. Was Canada any better? Nope – we are all in the same boat!
  • 43. Incidence Estimates from Other Chart Review Studies Incidence of AE Country N Year Preventable? USA (Utah 15,000 2000 2.9% - & Colorado) England 1,014 2001 11.7% 50% New 2004 12.9% 37% 6,579 Zealand Denmark 1,097 2001 9.0% 40.4% © May 11, 2006 43
  • 44. Incidence Estimates from Other Chart Review Studies Incidence of AE Country N Year Preventable? USA (Utah 15,000 2000 2.9% - & Colorado) England 1,014 2001 11.7% 50% New 2004 12.9% 37% 6,579 Zealand Denmark 1,097 2001 9.0% 40.4% Canada 3,745 2002 7.5% 39% © May 11, 2006 44
  • 45. Why did we do a Canadian study? • A critical element for accelerating safety work is that a country has its own data • The number is an underestimate and so the method cannot be used as an outcome measure for safety • Modeling can be carried out to delineate: – Possible areas for improvement – High hazard situations – Management opportunities © May 11, 2006 45
  • 46. When safety nets fail…. CT not CT report read, Unaware CT non-verbal no F/U done CT Report CT report missed ignored Radiology Residents Staff Consultants Family Doctor ……………………………………………………………………….. © May 11, 2006 46
  • 47. ….patients are harmed Especially, if: a. Patients remain uninformed b. Too trusting (“They would call if something was seen on the XRay…”) © May 11, 2006 47
  • 48. Acceptable risk Dangerous Regulated Ultra-safe (>1/1000) (<1/100K) 100,000 Total Lives Lost per year 10,000 “Acceptable public risk” 1,000 100 10 1 10 100 1,000 10,000 100,000 1,000,000 10,000,000 Number of encounters for each fatality © May 11, 2006 48
  • 49. Risky activities (Canada) Dangerous Regulated Ultra-safe (>1/1000) (<1/100K) 100,000 Total Lives Lost per year Hospitalisation 10,000 Driving Offshore rig 1,000 Commercial airlines Coal Mining timber Firearms 100 truckers construction Rock 10 Bungee Jumping Climbing Scuba diving for 25 hrs 1 10 100 1,000 10,000 100,000 1,000,000 10,000,000 Number of encounters for each fatality © May 11, 2006 49
  • 50. Unacceptable risk 15,000 deaths/yr Dangerous Regulated Ultra-safe (>1/1000) (<1/100K) 100,000 Total Lives Lost per year 1/165 risk Hospitalisation 10,000 of death 1,000 “Acceptable public risk” 100 10 1 10 100 1,000 10,000 100,000 1,000,000 10,000,000 Number of encounters for each fatality © May 11, 2006 50
  • 51. Our task Dangerous Regulated Ultra-safe (>1/1000) (<1/100K) 100,000 Total Lives Lost per year Hospitalisation 10,000 1,000 “Acceptable public risk” 100 10 1 10 100 1,000 10,000 100,000 1,000,000 10,000,000 Number of encounters for each fatality © May 11, 2006 51
  • 52. Our task Dangerous Regulated Ultra-safe (>1/1000) (<1/100K) 100,000 Hospitalisation Total Lives Lost per year 10,000 1,000 “Acceptable public risk” 100 10 1 10 100 1,000 10,000 100,000 1,000,000 10,000,000 Number of encounters for each fatality © May 11, 2006 52
  • 53. Our task Dangerous Regulated Ultra-safe (>1/1000) (<1/100K) 100,000 Total Lives Lost per year Hospitalisation 10,000 1,000 “Acceptable public risk” 100 10 1 10 100 1,000 10,000 100,000 1,000,000 10,000,000 Number of encounters for each fatality © May 11, 2006 53
  • 54. Study leads to change • By examining the individual stories of the AEs we determined that that the most common are: – failures in diagnosis – prescription of contraindicated drugs – incorrect management of organ failure © May 11, 2006 54
  • 55. • Pan-Canadian initiative • Modeled after US 100.000 lives Campaign • 3 nodes; Western, Ontario, Eastern • National Steering Committee • Secretariat - Canadian Patient Safety Institute • National Working Groups: – Measurement, Education, Communication © May 11, 2006 55
  • 56. • Deployment of Rapid Response Teams • Delivery of reliable, evidence based care for acute myocardial infarctions • Prevention of ADEs through Medication Reconciliation • Prevention of Central Line Infections • Prevention of Surgical Site Infections • Prevention of Ventilator - Associated Pneumonia © May 11, 2006 56 Safer Healthcare Now! Calgary, Alberta
  • 57. Western Node: • BC Patient Safety Taskforce • Canadian Patient Safety Institute • Health Quality Council of Alberta • Manitoba Patient Safety Institute Lead Planning Group: Dr. Ward Flemons Dr. Ross Baker Marlies van Dijk Dr. Peter Norton © May 11, 2006 57 Safer Healthcare Now! Calgary, Alberta
  • 58. Safer Healthcare Now! Enrollment © May 11, 2006 58
  • 59. © May 11, 2006 59
  • 60. © May 11, 2006 60
  • 61. © May 11, 2006 61
  • 62. © May 11, 2006 62
  • 63. © May 11, 2006 63
  • 64. © May 11, 2006 64
  • 65. © May 11, 2006 65
  • 66. Can change Tremendous prescribing variation that © May 11, 2006 66 Health Quality Council of Saskatchewan, 2004
  • 67. How does Canada compare? • 2004 Commonwealth Fund International Health Policy Survey in Australia, Canada, New Zealand, the United Kingdom, and the United States • Adults • 1400 per country and 3061 in the UK Schoen C, et. al. Primary care and health system performance: adults' experiences in five countries. Health Aff (Millwood). 2004 Jul-Dec;Suppl Web Exclusives:W4-487-503. © May 11, 2006 67
  • 68. When you need care or treatment, how often does the doctor tell you about treatment choices and ask for your ideas/opinions? 60% % saying sometimes/rarely or never 50% 40% 30% 20% 10% 0% Australia Canada New Zealand United United States © May 11, 2006 68 Kingdom
  • 69. Last time you were sick or needed medical attention, how quickly can you get an appointment to see a doctor? 60% 50% % saying 2 or more days 40% 30% 20% 10% 0% Australia Canada New Zealand United United States © May 11, 2006 69 Kingdom
  • 70. Rank 1 is best, 5 is worst Slide from Don Berwick August 2005 New Australia Canada UK US Zealand 2.5 4 2.5 1 5 Patient Safety Patient- 2 3 1 5 4 Centeredness 2 5 1 4 3 Timeliness 1 4 2 3 5 Efficiency 4.5 2.5 2.5 1 4.5 Effectiveness 2 4 3 1 5 Equity © May 11, 2006 70
  • 71. Conclusions: “win-win” • The study provides a starting point for understanding the incidence of AEs and the resulting burden of injury • Additional work is needed to explore the types of AEs and their contributing factors. • Efforts to improve medication safety and surgery are likely to play an important role in improving patient safety in Canadian hospitals • Additional research is needed on the incidence and types of AEs beyond the acute care hospital setting © May 11, 2006 71
  • 72. philip.hebert@sunnybrook.ca Thanks to Peter Norton, Ross Baker, Ed Etchells © May 11, 2006 72